Didier Raoult: h-index, Total Citations, and Citation Map
Didier Raoult's h-index is 227 (2131 i10-index, 261,546+ total citations across 3+ publications) according to Google Scholar as of May 2026. Didier Raoult is affiliated with IHU Méditerranée Infection, Aix Marseille Université, AP-HM CHU Timone, Marseille, FRANCE.
Didier Raoult is a researcher affiliated with IHU Méditerranée Infection, Aix Marseille Université, AP-HM CHU Timone, Marseille, FRANCE, specializing in Rickettsia, Infectious Diseases, Viruses. Their work has been cited 261,546 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Didier Raoult's Citation Metrics
Bibliometric impact based on 3 indexed publications.
- H-Index
- 227
- i10-Index
- 2131
- Total Citations
- 261,546
- Citing Countries
- 6
As of May 2026.
Didier Raoult has an h-index of 227 and 261,546 total citations across 3 publications, with research cited by institutions in 6 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Didier Raoult's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 261,546 citations for Didier Raoult
We've shown the most-cited 5,000. Unlock the full crawl (261,531 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
20206,979
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
3 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher established that gut microbiota are essential for the efficacy of CTLA-4 blockade in anticancer immunotherapy, a finding published in Science with nearly 4,000 citations.
The researcher conducted a clinical trial evaluating hydroxychloroquine and azithromycin for COVID-19, generating extensive scholarly discussion despite subsequent retraction.
The researcher published a seminal 2018 paper that has garnered over 6,000 citations, establishing a foundational contribution widely adopted by independent scholars across the field.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
